Risk factor
Very poor trading liquidity
Profitability factor
Favourable analyst view
About
Wiltrom Co., Ltd., an enterprise headquartered in Zhubei, Taiwan, specializes in the research, development, manufacturing, and global distribution of advanced implantable medical devices. Established in 2009, the company provides a diverse portfolio of surgical solutions to both domestic and international markets. Its comprehensive offerings include systems for spinal fixation, interbody fusion devices, synthetic bone graft substitutes, vertebral body augmentation systems, and specialized bone cement for vertebroplasty procedures.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is overvalued on EV/EBITDA.
Target Price
The average target price of 6767.TWO is 84.9 and suggests 254% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i